Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-12-26 Sale | 2023-12-27 6:08 pm | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 38,293 | $1.4397 | $55,129 | 300,594 (Direct) | View |
2023-12-21 Purchase | 2023-12-26 4:08 pm | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Volker Christopher Chief Operating Officer | 75,000 | $1.4 | $105,000 | 75,000 (Direct) | View |
2023-12-21 Sale | 2023-12-26 4:01 pm | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 11,707 | $1.4 | $16,390 | 338,887 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-21 Tax Withholding | 2024-04-23 10:21 am | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 7,250 | $1.15 | 176,661 (Direct) | View |
2024-04-21 Tax Withholding | 2024-04-23 10:09 am | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 2,030 | $1.15 | 323,204 (Direct) | View |
2024-04-21 Tax Withholding | 2024-04-23 09:53 am | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 19,673 | $1.15 | 1,164,836 (Direct) | View |
2024-03-31 Tax Withholding | 2024-04-02 11:52 am | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 252 | $1.2 | 183,911 (Direct) | View |
2024-03-31 Tax Withholding | 2024-04-02 11:45 am | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 90 | $1.2 | 325,234 (Direct) | View |
2024-03-31 Tax Withholding | 2024-04-02 11:34 am | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 2,239 | $1.2 | 1,184,509 (Direct) | View |
2024-02-29 Tax Withholding | 2024-03-04 2:10 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 252 | $1.21 | 184,163 (Direct) | View |
2024-02-29 Tax Withholding | 2024-03-04 2:01 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 2,239 | $1.21 | 1,186,748 (Direct) | View |
2024-02-29 Tax Withholding | 2024-03-04 1:50 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 90 | $1.21 | 325,324 (Direct) | View |
2024-02-18 Option Award | 2024-02-21 11:08 am | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 101,743 | $0 | 184,415 (Direct) | View |
2024-02-18 Option Award | 2024-02-21 10:57 am | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer | 113,717 | $0 | 244,117 (Direct) | View |
2024-02-18 Option Award | 2024-02-21 10:44 am | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 25,000 | $0 | 325,414 (Direct) | View |
2024-02-18 Option Award | 2024-02-21 10:14 am | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 663,497 | $0 | 1,188,987 (Direct) | View |
2024-01-31 Tax Withholding | 2024-02-01 1:51 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 252 | $1.25 | 82,672 (Direct) | View |
2024-01-31 Tax Withholding | 2024-02-01 1:41 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 90 | $1.25 | 300,414 (Direct) | View |
2024-01-31 Tax Withholding | 2024-02-01 1:29 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 2,239 | $1.25 | 525,490 (Direct) | View |
2023-12-31 Tax Withholding | 2024-01-03 1:30 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 252 | $1.58 | 82,924 (Direct) | View |
2023-12-31 Tax Withholding | 2024-01-03 1:29 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 90 | $1.58 | 300,504 (Direct) | View |
2023-12-31 Tax Withholding | 2024-01-03 1:29 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 2,239 | $1.58 | 527,729 (Direct) | View |
2023-11-30 Tax Withholding | 2023-12-04 4:32 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 252 | $1.45 | 83,176 (Direct) | View |
2023-11-30 Tax Withholding | 2023-12-04 4:24 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 90 | $1.45 | 350,594 (Direct) | View |
2023-11-30 Tax Withholding | 2023-12-04 4:09 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 2,239 | $1.45 | 529,968 (Direct) | View |
2023-11-10 Option Award | 2023-11-14 5:30 pm | N/A 2033-11-09 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Volker Christopher Chief Operating Officer | 324,560 | $0 | 324,560 (Direct) | View |
2023-11-09 Option Award | 2023-11-13 6:03 pm | N/A 2033-11-08 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 81,067 | $0 | 81,067 (Direct) | View |
2023-11-09 Option Award | 2023-11-13 5:53 pm | N/A 2033-11-08 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer | 89,283 | $0 | 89,283 (Direct) | View |
2023-11-09 Option Award | 2023-11-13 5:43 pm | N/A 2033-11-08 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 17,688 | $0 | 17,688 (Direct) | View |
2023-11-09 Option Award | 2023-11-13 5:30 pm | N/A 2033-11-08 | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 526,303 | $0 | 526,303 (Direct) | View |
2023-11-02 Tax Withholding | 2023-11-03 4:07 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 252 | $1.61 | 83,428 (Direct) | View |
2023-11-02 Tax Withholding | 2023-11-03 3:59 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 90 | $1.61 | 350,684 (Direct) | View |
2023-11-02 Tax Withholding | 2023-11-03 3:50 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 2,239 | $1.61 | 532,207 (Direct) | View |
2023-10-31 Tax Withholding | 2023-11-02 4:14 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 252 | $0.9 | 83,680 (Direct) | View |
2023-10-31 Tax Withholding | 2023-11-02 4:06 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 90 | $0.9 | 350,774 (Direct) | View |
2023-10-31 Tax Withholding | 2023-11-02 3:56 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 2,239 | $0.9 | 534,446 (Direct) | View |
2023-09-30 Tax Withholding | 2023-10-03 3:40 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer | 252 | $0.8904 | 83,932 (Direct) | View |
2023-09-30 Tax Withholding | 2023-10-03 3:31 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director | 90 | $0.8904 | 350,864 (Direct) | View |
2023-09-30 Tax Withholding | 2023-10-03 3:21 pm | N/A N/A | NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President | 2,239 | $0.8904 | 536,685 (Direct) | View |